Impact of recanalization, reperfusion, and collateral flow on clinical efficacy

Stroke

Volumn 44, Issue SUPPL. 1, 2013, Pages

  Albers, Gregory W ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brain ischemia; Collateral flow; Diffusion MRI; Perfusion MRI; Reperfusion

Indexed keywords

CLINICAL OBSERVATION; COLLATERAL CIRCULATION; CONFERENCE PAPER; DIFFUSION WEIGHTED IMAGING; IMAGE ANALYSIS; PRIORITY JOURNAL; RECANALIZATION; REPERFUSION;

BRAIN ISCHEMIA; COLLATERAL FLOW; DIFFUSION MRI; PERFUSION MRI; REPERFUSION;

CEREBROVASCULAR CIRCULATION; CLINICAL TRIALS AS TOPIC; COLLATERAL CIRCULATION; DIFFUSION MAGNETIC RESONANCE IMAGING; ECHO-PLANAR IMAGING; ENDOVASCULAR PROCEDURES; HUMANS; REPERFUSION; STROKE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 84880266402     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.000258     Document Type: Conference Paper

References (9)

1. Saver J. Time is brain -quantified. Stroke. 2006;37(1):10
2. Chemmanam T, Campbell BC, Christensen S, Nagakane Y, Desmond PM, Bladin CF, et al.; EPITHET Investigators. Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch. Neurology. 2010;75:1040-1047.
3. Campbell BC, Purushotham A, Christensen S, Desmond PM, Nagakane Y, Parsons MW, et al.; EPITHET-DEFUSE Investigators. The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent. J Cereb Blood Flow Metab. 2012;32:50-56.
4. Olivot JM, Mlynash M, Thijs VN, Kemp S, Lansberg MG, Wechsler L, et al. Optimal Tmax threshold for predicting penumbral tissue in acute stroke. Stroke. 2009;40:469-475.
5. Zaro-Weber O, Moeller-Hartmann W, Heiss WD, Sobesky J. Maps of time to maximum and time to peak for mismatch definition in clinical stroke studies validated with positron emission tomography. Stroke. 2010;41:2817-2821.
6. Inoue M, Mlynash M, Straka M, et al. Patients with the Malignant Profile within 3 hours of symptom onset have very poor outcomes following IV tPA therapy. Stroke.2012;43:2494-2496.
7. Lansberg MG, Lee J, Christensen S, Straka M, De Silva DA, Mlynash M, et al. RAPID automated patient selection for reperfusion therapy: a pooled analysis of the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) and the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study. Stroke. 2011;42: 1608-1614.
8. Lansberg MG, Straka M, Kemp S, Mlynash M, Wechsler LR, Jovin TG, et al.; DEFUSE 2 Study Investigators. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol. 2012;11:860-867.
9. Mlynash M, Lansberg MG, De Silva DA, Lee J, Christensen S, Straka M, et al.; DEFUSE-EPITHET Investigators. Refining the definition of the malignant profile: insights from the DEFUSE-EPITHET pooled data set. Stroke. 2011;42:1270-1275.